This week, www.selectscience.net reported on 28 news stories the day they
happened, so if you need to keep up to speed on the latest business
developments in chemistry and life science, make www.selectscience.net part
of your daily routine.
Andrew Smith (andrew at selectscience.net)
Editor, www.selectscience.net
This week's headlines were:
Rheometric Scientific Reports Improvement in 1998 Results
Molecular Applications Group and Monsanto Company Sign Discovery Partnership
Agreement On Prediction of Gene and Protein Function
Stanford Announce Novel Gene Therapy Approach for Cystic Fibrosis
Genentech Discussing HCG Settlement With U.S. Government
Neurocrine Announces Successful Completion of Phase Ib Insomnia Trial
Biogen Reports Record First Quarter 1999 Results
Genset Achieves a Significant Milestone in Its Prostate Cancer Alliance with
Synthélabo
Quark Biotech Signs $19 Million Stroke Gene Agreement With Fujisawa
Pharmaceutical
Biotech Industry Adopts Statement Opposing Discriminatory Misuse Of Medical
Information
DIANON Systems, Inc. Signs Definitive Agreement to Acquire Assets of Kyto
Meridien Diagnostics, LLC
Molecular Innovations, Inc. Receives SBIR Phase I Grant to Develop a Nucleic
Acid-Based Test for the Food Pathogen, Listeria
New Chairman for Nycomed Amersham
Updated Medical Device Industry Releases Legislative Proposals to Expedite
Innovative Products into the Medicare System
Biotech Industry Adopts Statement Opposing Discriminatory Misuse Of Medical
Information
Dow AgroSciences & Integrated Genomics Announce Research and Licensing
Agreement
Molecular Probes Grants Cellomics Exclusive License to Key Fluorescence
Technologies for High Content Screening
Curative Health Services Receives Subpoena
Extended Regulatory Approval for Celsis Technology
Bio-Rad Laboratories Acquires Patent Portfolio For Hereditary
Hemochromatosis Gene
Abbott Reports Increase in Sales, Earnings in First Quarter
Aurora Biosciences Extends Ion Channel Technology Platform with Exclusive
License to Cell Membrane Potential Measurement Technique
BIO Response to NBAC on Stem Cell Research
Pharmacia & Upjohn and Versicor Collaborate On New Oxazolidinone
Antibacterials
Astra and Zeneca Complete Merger
Genzyme Tissue Repair Announces Proposed Terms For Transfer of its NeuroCell
Program to Genzyme General
Cubist Pharmaceuticals Releases 1998 Annual Report Electronically
Rohm And Haas Extends Morton Tender offer To April 16, 1999
Waters Issued Patent Issued for Novel Solid-Phase Extraction Sorbent
Technology
Karin Eastham Resigns as Vice President, Finance and Administration and
Chief Financial Officer of CombiChem
Delsys Forms Collaboration with The R.W. Johnson Pharmaceutical Research
Institute to Develop New Technology for Drug Delivery
GPC AG and Evotec Biosystems AG Enter Drug Discovery Alliance for Novel
Genomics-Derived Antibacterial Target
Idun Appoints John J. Serbin, Ph.D. as Vice President, Corporate Development
Nanogen Advances SNP Identification Technology
US FDA Approves First Biologic Therapy for Clotting Disorder
